Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2.11B P/E - EPS this Y 52.00% Ern Qtrly Grth -
Income -33.7M Forward P/E 242.86 EPS next Y 208.30% 50D Avg Chg -11.00%
Sales 170.89M PEG - EPS past 5Y - 200D Avg Chg -19.00%
Dividend N/A Price/Book 4.20 EPS next 5Y - 52W High Chg -36.00%
Recommedations 3.00 Quick Ratio 3.72 Shares Outstanding 124.34M 52W Low Chg 41.00%
Insider Own 66.41% ROA -6.56% Shares Float 40.95M Beta 0.52
Inst Own 35.24% ROE -7.03% Shares Shorted/Prior 2.53M/2.84M Price 17.00
Gross Margin 66.88% Profit Margin -19.72% Avg. Volume 109,659 Target Price 26.00
Oper. Margin -86.75% Earnings Date Aug 7 Volume 60,119 Change -5.50%
About Olink Holding AB (publ)

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and data analysis and bioinformatics services. In addition, the company offers Olink normalized protein expression (NPX) data processing software, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in Sweden, the United States, rest of the Americas, rest of Europe, the Middle East, Africa, Japan, and internationally. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden. As of July 10, 2024, Olink Holding AB (publ) operates as a subsidiary of Thermo Fisher Scientific Inc..

Olink Holding AB (publ) News
07/11/24 Notice to attend the Extra General Meeting of Olink Holding AB (publ)
07/10/24 Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period
07/09/24 Olink's (OLK) Acquisition by Thermo Fisher Gets UK CMA Nod
07/08/24 Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher
07/05/24 Report from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024
07/03/24 Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
06/19/24 Olink Holding AB (publ) (NASDAQ:OLK): Is Breakeven Near?
06/06/24 Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
05/30/24 Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis
05/13/24 Olink Holding AB (publ) Sponsored ADR (OLK) Reports Q1 Loss, Lags Revenue Estimates
05/13/24 Olink reports first quarter 2024 financial results
04/19/24 Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
04/02/24 Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease
03/28/24 Olink Holding AB (publ) (NASDAQ:OLK) Just Reported And Analysts Have Been Cutting Their Estimates
03/27/24 These Analysts Think Olink Holding AB (publ)'s (NASDAQ:OLK) Sales Are Under Threat
03/25/24 Olink reports fourth quarter and full year 2023 financial results
03/25/24 Olink publishes 2023 annual report
03/15/24 Notice to attend the Annual General Meeting of Olink Holding AB (publ)
03/08/24 Olink announces change of date for Annual General Meeting
03/01/24 Companies Like Olink Holding (NASDAQ:OLK) Can Afford To Invest In Growth
OLK Chatroom

User Image TacoMan81 Posted - 4 months ago

@Nelsin 525 is the low. My target is 615 by 08/30. I think it's setting up for a monster August. Newly declared dividend and $OLK acquisition haven't been fixed into the price yet. Crossing my fingers they also announce a buyback

User Image PayTrader Posted - 4 months ago

$ELF $OLK $TMO $UNH

User Image TacoMan81 Posted - 4 months ago

$UNH, $TMO & $ELF are earning giants. Pay attention to $ELF Monday morning as it slides back to 202-205 and hopefully 198-200. Always a great idea to buy calls in that range. Follow it's patterns closely and you'll see why it's the gift that keeps on giving. $UNH earnings Tuesday morning. Despite the recent pop, I still see another 8-10% upside. $TMO is my monster for the summer. Biggest medical technology company in the world with tremendous upside for years to come. Newly declared cash dividend and $OLK acquisition will send it to the moon with a +12-15%. These are my monsters this month. I know we all love the mag 7 but these companies will provide a more bang for your buck in my opinion. Research and trade carefully. Predictions for 08/30 $ELF 240-250 $UNH 580-600 $TMO 590-625

User Image TacoMan81 Posted - 4 months ago

$TSLA while you're all fighting over this disaster, I'll drop you an earnings giant. $TMO is going to explode. It's my big bull of the month. 12%-15% upside. Declared a quarterly cash dividend after close today and acquired $OLK two days ago. Monster of a stock. Check it out and trade carefully.

User Image tradethehalt Posted - 4 months ago

$OLK trade halt (T12) was alerted to our Members at 7:50pm EDT. Halt price: $26.02 Vol: 1.89M.

User Image HaltTradeAlert Posted - 4 months ago

$OLK Halt Time: 19:50:00 Issue Symbol: OLK Reason Code: T12 Last Price: $26.08 Market Cap: $3.2 B Volume: 1.9 M Relative Volume: 1.1 Shares Outstanding: 124.3 M Percentage Change: N/A Our members get this alert real time and sent to their phone just like a text. Members also get free real time news catalyst alerts! Go to our website and join our community for free! www.HaltTradeAlert.com

User Image Stocksrunner Posted - 4 months ago

Hot Streaks Continue! 🔥🚀 $TSLA leading the pack with a 9-day winning streak! 🏆 $GSM matching that energy! 💯 $OLK not far behind with 8 days of green! 🟢 Who's riding these rockets? 🚀 Will the momentum continue tomorrow? 🤔 Let's go, bulls! 🐂💪

User Image CaridinaCapital Posted - 4 months ago

It's done, $TMO has been cleared to acquire Swedish biotech company $OLK. That's a +6.4% return / +16.2% annualized return for me and win 4/4 on merger arb deals. Merger arbitrage is a great strategy if you pick reasonable deals and be patient 👌

User Image Mergerbrief Posted - 4 months ago

$OLK $TMO - Tender Offer Expires @ 5pm MergerBrief.com

User Image Stock_Titan Posted - 4 months ago

$OLK Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher https://www.stocktitan.net/news/OLK/olink-announces-receipt-of-cma-clearance-for-proposed-acquisition-by-pq8a3vk6lms4.html

User Image Defpotec Posted - 5 months ago

$OLK German regulators clear the acquisition by $TMO. UK CMA decision still pending after phase I investigation.

User Image StockInvest_us Posted - 5 months ago

Signal alert: $OLK - Overbought Trend Short (Overvalued) https://stockinvest.us/l/SEi58VNbg9

User Image Stock_Titan Posted - 05/30/24

$OLK Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis https://www.stocktitan.net/news/OLK/researchers-use-olink-r-explore-to-identify-circulating-proteins-xlyittslgge1.html

User Image epsguid Posted - 6 months ago

$OLK reported a loss of $0.13, consensus was ($0.12) via @eWhispers #epsmiss http://eps.sh/d/olk

User Image DonCorleone77 Posted - 6 months ago

$OLK Olink reports Q1 EPS (13c), consensus (15c) Reports Q1 revenue $28.8M, consensus $30.22M.

User Image Stock_Titan Posted - 6 months ago

$OLK Olink reports first quarter 2024 financial results https://www.stocktitan.net/news/OLK/olink-reports-first-quarter-2024-financial-8zzl5v9aaxi4.html

User Image CTFNLighthouse Posted - 6 months ago

$OLK $TMO The UK Competition and Markets Authority has launched a Phase 1 review into Thermo Fisher's proposed acquisition of Olink. The agency has until July 8 to decide on the matter.

User Image Stock_Titan Posted - 7 months ago

$OLK Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024 https://www.stocktitan.net/news/OLK/report-from-the-annual-general-meeting-of-olink-holding-ab-publ-on-uh8ukq8fnj1v.html

User Image Stocksrunner Posted - 7 months ago

Warren Buffett's advice to be greedy when others are fearful applies to $ARGX $BLTE and $OLK Technical analysis shows these stocks are in oversold territory, which could present a buying opportunity for risk-tolerant investors.

User Image Stock_Titan Posted - 7 months ago

$OLK Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease https://www.stocktitan.net/news/OLK/olink-r-insight-unveils-open-access-map-of-the-human-proteome-aiding-gq2wqu02kkib.html

User Image DonCorleone77 Posted - 03/25/24

$OLK Olink will not host conference call Due to the pending acquisition of Olink by Thermo Fisher Scientific Inc., Olink will not be hosting a conference call.

User Image DonCorleone77 Posted - 03/25/24

$OLK Olink reports Q4 EPS (6c), consensus 15c Reports Q4 revenue $68.6M, consensus $89.86M.

User Image Stock_Titan Posted - 03/25/24

$OLK Olink reports fourth quarter and full year 2023 financial results https://www.stocktitan.net/news/OLK/olink-reports-fourth-quarter-and-full-year-2023-financial-3yu0kuyaay14.html

User Image Stock_Titan Posted - 8 months ago

$OLK Notice to attend the Annual General Meeting of Olink Holding AB (publ) https://www.stocktitan.net/news/OLK/notice-to-attend-the-annual-general-meeting-of-olink-holding-ab-rkzhchyxolpj.html

User Image Stock_Titan Posted - 8 months ago

$OLK Olink announces change of date for Annual General Meeting https://www.stocktitan.net/news/OLK/olink-announces-change-of-date-for-annual-general-18bccosmu3dt.html

User Image G101SPM Posted - 8 months ago

#OPTIONACTION $OLK March 23 Calls (volume: 8008, open int: 0, implied vol: ~181%, prev day implied vol: 23%). $LBRT June 25 Calls (volume: 1000, open int: 0, implied vol: ~64.64%, prev day implied vol: 38.64%). Co is expected to report earnings in mid April. $SIRI April 3.5 Puts (volume: 3001, open int: 0, implied vol: ~89.26%, prev day implied vol: 60.26%). Co is expected to report earnings in late April. $WAL March 57 Puts (volume: 1699, open int: 27, implied vol: ~91.3%, prev day implied vol: 65.3%). Co is expected to report earnings in mid April.

User Image TickerDD_com Posted - 8 months ago

From 3/1/2024, looking back across 22 Month-Ends for OLK, Percentage Change of Average Monthly Price had More Negatives (55%) while Percentage Change of Average Monthly Volume had More Positives (95%) $OLK #OLK #OLKStock #TickerDD #OLKPrice https://www.youtube.com/watch?v=hqQHtSpBxx0

User Image CTFNLighthouse Posted - 8 months ago

$OLK $TMO Thermo Fisher Scientific extended the expiration date of its $26-per-share tender offer for Olink. The offer is now scheduled to expire at 5pm ET on April 30. As of February 29, approximately 95.2% of Olink’s outstanding shares have been validly tendered into the offer.

User Image Mergerbrief Posted - 02/23/24

$OLK $TMO - UK CMA(Comment Period Expires) Mergerbrief.com

User Image DailyStocksPicks Posted - 8 months ago

My Oversold Stock Pick #4 Today: Olink Holding AB (publ) ($OLK) analyzes proteins for medical insights.The oversold status of Olink Holding AB (publ) (OLK) stock can largely be attributed to the news that Thermo Fisher Scientific Inc. plans to acquire Olink. This significant development reflects the growing importance of proteomics in advancing life science research and precision medicine, with Thermo Fisher intending to enhance its offerings by integrating Olink's pioneering proteomics technologies. The acquisition, backed by major shareholders and expected to close by mid-2024, is projected to initially dilute Thermo Fisher's adjusted earnings per share, though it is anticipated to contribute positively in the longer term. This move has likely influenced market perceptions and led to the current trading condition of OLK stock​​​​. For more details https://youtu.be/ezSZP5XHe2I

Analyst Ratings
Morgan Stanley Equal-Weight Mar 26, 24
Canaccord Genuity Hold Mar 26, 24
Morgan Stanley Equal-Weight Oct 24, 23
Scotiabank Sector Perform Oct 18, 23
Morgan Stanley Equal-Weight Aug 10, 23
Morgan Stanley Equal-Weight May 15, 23
Goldman Sachs Neutral Feb 23, 23
Morgan Stanley Equal-Weight Feb 22, 23
Goldman Sachs Neutral Feb 22, 23